Artemis Therapeutics Inc. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced operating income was USD 46,000 compared to USD 57,000 a year ago. Net loss was USD 48,000 compared to USD 6,000 a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.01 a year ago. For the half year, operating income was USD 81,000 compared to USD 76,000 a year ago. Net loss was USD 84,000 compared to USD 27,000 a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.01 a year ago.